Shares of Arrowhead Pharmaceuticals (ARWR) catapulted Tuesday after the company inked a broad licensing deal with Sarepta Therapeutics (SRPT) for an array of gene-silencing...
BridgeBio Pharma (BBIO) snagged Food and Drug Administration approval for a rival to Pfizer's (PFE) blockbuster heart drug, and BridgeBio stock catapulted by double...
AbbVie (ABBV) stock popped Friday after an analyst upgraded it on the remaining opportunity for its Cerevel takeover despite a huge misstep in schizophrenia...